Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
8.24
+0.41 (5.31%)
At close: Aug 29, 2025, 4:00 PM
8.00
-0.23 (-2.85%)
After-hours: Aug 29, 2025, 7:50 PM EDT
Cyclacel Pharmaceuticals Market Cap
Cyclacel Pharmaceuticals has a market cap or net worth of $18.44 million as of August 29, 2025. Its market cap has increased by 544.17% in one year.
Market Cap
18.44M
Enterprise Value
14.17M
1-Year Change
544.17%
Ranking
Category
Stock Price
$8.24
Market Cap Chart
Since May 16, 2006, Cyclacel Pharmaceuticals's market cap has decreased from $90.74M to $18.44M, a decrease of -79.68%. That is a compound annual growth rate of -7.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 18.44M | 679.98% |
| Dec 31, 2024 | 2.36M | -13.14% |
| Dec 29, 2023 | 2.72M | -67.46% |
| Dec 30, 2022 | 8.36M | -78.44% |
| Dec 31, 2021 | 38.79M | 2.12% |
| Dec 31, 2020 | 37.98M | 230.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |